First Time Loading...

Nuvo Pharmaceuticals Inc
TSX:MRV

Watchlist Manager
Nuvo Pharmaceuticals Inc Logo
Nuvo Pharmaceuticals Inc
TSX:MRV
Watchlist
Price: 1.35 CAD Market Closed
Updated: May 4, 2024
Section:
 

Wall Street
Price Targets

MRV Price Targets Summary
Nuvo Pharmaceuticals Inc

Wall Street analysts forecast MRV stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MRV is 1.35 CAD .

MRV Lowest Forecast
Wall Street Target
Not Available
MRV Average Forecast
Wall Street Target
1.35 CAD
0% Downside
MRV Highest Forecast
Wall Street Target
Not Available
Lowest
Price Target
Not Available
Average
Price Target
1.35 CAD
0% Upside
Highest
Price Target
Not Available
Nuvo Pharmaceuticals Inc Competitors:
Price Targets
AXSM
Axsome Therapeutics Inc
65% Upside
PHAT
Phathom Pharmaceuticals Inc
131% Upside
600789
Shandong Lukang Pharmaceutical Co Ltd
72% Upside
C
CURA
Curaleaf Holdings Inc
29% Upside
AXSM
Axsome Therapeutics Inc
65% Upside
PHAT
Phathom Pharmaceuticals Inc
131% Upside
600789
Shandong Lukang Pharmaceutical Co Ltd
72% Upside
C
CURA
Curaleaf Holdings Inc
29% Upside
688578
Shanghai Allist Pharmaceuticals Co Ltd
38% Downside
MDWD
Mediwound Ltd
56% Upside
K
GUD
Knight Therapeutics Inc
16% Upside
AGY
Allergy Therapeutics PLC
460% Upside

Revenue
Forecast

Revenue Estimate
Nuvo Pharmaceuticals Inc

For the last 8 years the compound annual growth rate for Nuvo Pharmaceuticals Inc's revenue is 18%. The projected CAGR for the next 2 years is 5%.

18%
Past Growth
5%
Estimated Growth
Estimates Accuracy
0%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Nuvo Pharmaceuticals Inc

The compound annual growth rate of Nuvo Pharmaceuticals Inc's operating income for the next 4 years is -26%.

N/A
Past Growth
-26%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Nuvo Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-28%
Average Miss
What are analyst estimates?

See Also

Summary
MRV intrinsic value, competitors valuation, and company profile.
DCF Valuation
MRV stock valuation using Discount Cash Flow valuation method.
Relative Valuation
MRV stock valuation using valuation multiples.
Wall Street Estimates
MRV price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
MRV stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is MRV's stock price target?
Price Target
1.35 CAD

According to Wall Street analysts, the average 1-year price target for MRV is 1.35 CAD .

What is Nuvo Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
5%

For the last 8 years the compound annual growth rate for Nuvo Pharmaceuticals Inc's revenue is 18%. The projected CAGR for the next 2 years is 5%.

What is Nuvo Pharmaceuticals Inc's Operating Income forecast?
Projected CAGR
-26%

The compound annual growth rate of Nuvo Pharmaceuticals Inc's operating income for the next 4 years is -26%.

ALPHA SPREAD
Join more than 134,200+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.